Skip to main content

Brain and CNS.

39 Phase 1 studies recruiting right now, most recently updated first.

Open the Phase 2 page · a list of only those studies

Triangle is made by Triangle Health, Inc.

Brain and CNS39 studies

Brain Tumor, RecurrentPhase 1NCT06666712Papers

Topotecan

Chronic CED of TPT for Recurrent Malignant Glioma

Jeffrey N. BruceOpen the brief

Glioblastoma MultiformePhase 1/2NCT01269853Papers

Bevacizumab

Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA

Northwell HealthOpen the brief

Pediatric Recurrent Central Nervous System TumorsPhase 1NCT03988283

Personalized neoantigen DNA vaccine

Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Central Nervous System Tumors

Washington University School of MedicineOpen the brief

High Grade GliomaPhase 1/2NCT06504381

DB107-RRV

DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma

University of California, San FranciscoOpen the brief

Recurrent GlioblastomaPhase 1NCT06917885

CUE-102

CUE-102 in Recurrent Glioblastoma

David Reardon, MDOpen the brief

Solid Tumor (Excluding CNS)Phase 1NCT07148050

SC-CAR.GPC3xIL15.21 CAR T cells

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

Seattle Children's HospitalOpen the brief

Glioma of Spinal CordPhase 1NCT04196413Papers

GD2 CAR T cells

GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)

Stanford UniversityOpen the brief

Pediatric Brain CancerPhase 1NCT05106296Papers

Ibrutinib + Indoximod

Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer

Theodore S. JohnsonOpen the brief

Clinical trials: Phase 1 and Phase 2, explained